Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.
暂无分享,去创建一个
P. Lockhart | S. Haas | K. Hogan | M. Bahlo | C. Galea | D. Phelan | V. Kalscheuer | M. Delatycki | P. James | A. Churchyard | D. Amor | P. D’Adamo | R. Gregg | G. R. Wilson | C. Mclean | R. Leventer | G. Mellick | S. Hayflick | Joe C H Sim | Maila Giannandrea | Jessica R. Riseley | Sarah E. M. Stephenson | E. Fitzpatrick | Kate Pope | C. Bromhead | D. Wargowski | C. Lawrence | Yujing Gao | Greta Gillies | Nicholas Salce | L. Stanford | Ashley P L Marsh | M. Mignogna | K. Pope | J. Riseley | S. Stephenson | Gabrielle R. Wilson | Christopher H. Lawrence | C. Mclean | S. Haas
[1] K. Õunap,et al. Increased Dosage of RAB39B Affects Neuronal Development and Could Explain the Cognitive Impairment in Male Patients with Distal Xq28 Copy Number Gains , 2014, Human mutation.
[2] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[3] A. R. Khan,et al. Structural biology of Arf and Rab GTPases' effector recruitment and specificity. , 2013, Structure.
[4] T. Outeiro,et al. alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson’s disease pathology , 2013, Journal of Molecular Medicine.
[5] H. H. Park. Structural Basis of Membrane Trafficking by Rab Family Small G Protein , 2013, International journal of molecular sciences.
[6] G. Halliday,et al. Can we clinically diagnose dementia with Lewy bodies yet? , 2013, Translational Neurodegeneration.
[7] Emil Alexov,et al. An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity. , 2012, Human molecular genetics.
[8] L. Petrucelli,et al. Disruption of protein quality control in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.
[9] H. Schipper,et al. Neurodegeneration with brain iron accumulation - clinical syndromes and neuroimaging. , 2012, Biochimica et biophysica acta.
[10] Blaine R. Roberts,et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.
[11] Simon C. Potter,et al. Using genome-wide complex trait analysis to quantify ‘ missing heritability ’ in Parkinson ’ s disease , 2012 .
[12] Christine Klein,et al. Genetics of Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.
[13] Nicholas Eriksson,et al. Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.
[14] P. Novick,et al. Role of Rab GTPases in membrane traffic and cell physiology. , 2011, Physiological reviews.
[15] M. Rooman,et al. PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality , 2011, BMC Bioinformatics.
[16] P. Lewis,et al. A Tangled Web – Tau and Sporadic Parkinson's Disease , 2010, Front. Psychiatry.
[17] M. Freeman,et al. Wallerian degeneration, wld(s), and nmnat. , 2010, Annual review of neuroscience.
[18] J. Gécz,et al. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. , 2010, American journal of human genetics.
[19] Hao Hu,et al. Mutation screening in 86 known X-linked mental retardation genes by droplet-based multiplex PCR and massive parallel sequencing , 2009, The HUGO Journal.
[20] Sonja W. Scholz,et al. Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.
[21] P. Silburn,et al. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. , 2009, Parkinsonism & related disorders.
[22] 目黒 玲子. Cellular and subcellular localizations of nonheme ferric and ferrous iron in the rat brain : a light and electron microscopic study by the perfusion-Perls and -Turnbull methods , 2009 .
[23] Johannes Söding,et al. Fast and accurate automatic structure prediction with HHpred , 2009, Proteins.
[24] A. Gregory,et al. Clinical and genetic delineation of neurodegeneration with brain iron accumulation , 2008, Journal of Medical Genetics.
[25] S. Lindquist,et al. The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis , 2008, Proceedings of the National Academy of Sciences.
[26] S. Lindquist,et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. , 2008, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Rowe,et al. In Vitro Characterization of Pittsburgh Compound-B Binding to Lewy Bodies , 2007, The Journal of Neuroscience.
[28] Shuangye Yin,et al. Eris: an automated estimator of protein stability , 2007, Nature Methods.
[29] M. Re,et al. Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease , 2007, Neuropsychiatric disease and treatment.
[30] Ben M. Webb,et al. Comparative Protein Structure Modeling Using Modeller , 2006, Current protocols in bioinformatics.
[31] S. Lindquist,et al. α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.
[32] A. Lang,et al. Interface between tauopathies and synucleinopathies: A tale of two proteins , 2006, Annals of neurology.
[33] H. Muller. The American Journal of Human Genetics Vol . 2 No . 2 June 1950 Our Load of Mutations 1 , 2006 .
[34] Haipeng Cheng,et al. Isolation and characterization of a human novel RAB (RAB39B) gene , 2002, Cytogenetic and Genome Research.
[35] D. Toniolo,et al. Mapping to distal Xq28 of nonspecific X-linked mental retardation MRX72: linkage analysis and clinical findings in a three-generation Sardinian family. , 2000, American journal of medical genetics.
[36] Fran Maher,et al. Non-Aβ Component of Alzheimer's Disease Amyloid (NAC) Revisited: NAC and α-Synuclein Are Not Associated with Aβ Amyloid , 1999 .
[37] C. Masters,et al. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid. , 1999, The American journal of pathology.
[38] Francisco Melo,et al. ANOLEA: A WWW Server to Assess Protein Structures , 1997, ISMB.
[39] D. Eisenberg,et al. VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.
[40] D S Moss,et al. Main-chain bond lengths and bond angles in protein structures. , 1993, Journal of molecular biology.
[41] D. Eisenberg,et al. Assessment of protein models with three-dimensional profiles , 1992, Nature.
[42] R. Laxová,et al. Waisman syndrome, a human X-linked recessive basal ganglia disorder with mental retardation: localization to Xq27.3-qter. , 1991, Genomics.
[43] J. Opitz,et al. An X-linked recessive basal ganglia disorder with mental retardation. , 1985, American journal of medical genetics.